Form 8-K - Current report:
SEC Accession No. 0001628280-25-038547
Filing Date
2025-08-07
Accepted
2025-08-07 06:18:53
Documents
15
Period of Report
2025-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zlab-20250807.htm   iXBRL 8-K 29911
2 EX-99.1 zlab-202587x8kex991.htm EX-99 183258
7 image_0.jpg GRAPHIC 11510
  Complete submission text file 0001628280-25-038547.txt   406816

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zlab-20250807.xsd EX-101.SCH 2151
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT zlab-20250807_def.xml EX-101.DEF 15888
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zlab-20250807_lab.xml EX-101.LAB 27758
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zlab-20250807_pre.xml EX-101.PRE 16626
17 EXTRACTED XBRL INSTANCE DOCUMENT zlab-20250807_htm.xml XML 4050
Mailing Address 4560 JINKE ROAD BLDG. 1, 4F, PUDONG SHANGHAI China
Business Address 4560 JINKE ROAD BLDG. 1, 4F, PUDONG SHANGHAI China 862161632588
Zai Lab Ltd (Filer) CIK: 0001704292 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)